FELIX FONGE: Open Payments
NPI 1386994812 · HINSDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 31 payments from 8 companies in 2025. Trend: 2023 $184 · 2024 $545 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $194 |
| Abbott Laboratories | 4 | $177 |
| PFIZER INC. | 7 | $141 |
| Lilly USA, LLC | 4 | $102 |
| E.R. Squibb & Sons, L.L.C. | 4 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Novo Nordisk Inc | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: CAPLYTA, FREESTYLE LIBRE 3, JARDIANCE, COBENFY, ELIQUIS, PREVNAR 20, Ozempic, GEMTESA.
Industry payments across IL — which companies pay providers there.
